These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 31066995)

  • 1. Precisely Controlled Delivery of Abaloparatide through Injectable Hydrogel to Promote Bone Regeneration.
    Ning Z; Tan B; Chen B; Lau DSA; Wong TM; Sun T; Peng S; Li Z; Lu WW
    Macromol Biosci; 2019 Jun; 19(6):e1900020. PubMed ID: 31066995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gelatin Methacryloyl-Riboflavin (GelMA-RF) Hydrogels for Bone Regeneration.
    Goto R; Nishida E; Kobayashi S; Aino M; Ohno T; Iwamura Y; Kikuchi T; Hayashi JI; Yamamoto G; Asakura M; Mitani A
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33561941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gelatin Templated Polypeptide Co-Cross-Linked Hydrogel for Bone Regeneration.
    Qiao Y; Liu X; Zhou X; Zhang H; Zhang W; Xiao W; Pan G; Cui W; Santos HA; Shi Q
    Adv Healthc Mater; 2020 Jan; 9(1):e1901239. PubMed ID: 31814318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of abaloparatide, a human parathyroid hormone-related peptide analog, on bone mineral density in postmenopausal women with osteoporosis.
    Leder BZ; O'Dea LS; Zanchetta JR; Kumar P; Banks K; McKay K; Lyttle CR; Hattersley G
    J Clin Endocrinol Metab; 2015 Feb; 100(2):697-706. PubMed ID: 25393645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abaloparatide, the second generation osteoanabolic drug: Molecular mechanisms underlying its advantages over the first-in-class teriparatide.
    Bhattacharyya S; Pal S; Chattopadhyay N
    Biochem Pharmacol; 2019 Aug; 166():185-191. PubMed ID: 31136739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphate functionalization and enzymatic calcium mineralization synergistically enhance oligo[poly(ethylene glycol) fumarate] hydrogel osteoconductivity for bone tissue engineering.
    George MN; Liu X; Miller AL; Xu H; Lu L
    J Biomed Mater Res A; 2020 Mar; 108(3):515-527. PubMed ID: 31702863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The preventive effect of photocrosslinked Hep/GelMA hydrogel loaded with PRF on MRONJ.
    Tao L; Gao Y; Li Y; Yang L; Yao J; Huang H; Yu J; Han B; Wang B; Liu Z
    BMC Oral Health; 2024 Aug; 24(1):1010. PubMed ID: 39210345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Controlled Release of Epigenetically-Enhanced Extracellular Vesicles from a GelMA/Nanoclay Composite Hydrogel to Promote Bone Repair.
    Man K; Barroso IA; Brunet MY; Peacock B; Federici AS; Hoey DA; Cox SC
    Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35055017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Injectable thermo-responsive Poloxamer hydrogel/methacrylate gelatin microgels stimulates bone regeneration through biomimetic programmed release of SDF-1a and IGF-1.
    Zhong Q; Wang D; Mai H; Chen R; Xu Y; Lei M; Xie J; Tang Z; Fu J; Chen Y; Wang J; Shi Z; Cheng H
    Int J Biol Macromol; 2024 Jun; 271(Pt 2):132742. PubMed ID: 38821297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Handling Parathormone Receptor Type 1 in Skeletal Diseases: Realities and Expectations of Abaloparatide.
    Ardura JA; Portal-Núñez S; Alonso V; Bravo B; Gortazar AR
    Trends Endocrinol Metab; 2019 Oct; 30(10):756-766. PubMed ID: 31409530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel calcium-accumulating peptide/gelatin in situ forming hydrogel for enhanced bone regeneration.
    Jo BS; Lee Y; Suh JS; Park YS; Lee HJ; Lee JY; Cho J; Lee G; Chung CP; Park KD; Park YJ
    J Biomed Mater Res A; 2018 Feb; 106(2):531-542. PubMed ID: 28975732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abaloparatide versus teriparatide: a head to head comparison of effects on fracture healing in mouse models.
    Bernhardsson M; Aspenberg P
    Acta Orthop; 2018 Dec; 89(6):674-677. PubMed ID: 30334479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined Molybdenum Gelatine Methacrylate Injectable Nano-Hydrogel Effective Against Diabetic Bone Regeneration.
    Liao X; Shen M; Li T; Feng L; Lin Z; Shi G; Pei G; Cai X
    Int J Nanomedicine; 2023; 18():5925-5942. PubMed ID: 37881608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sustained Release of Melatonin from GelMA Liposomes Reduced Osteoblast Apoptosis and Improved Implant Osseointegration in Osteoporosis.
    Xiao L; Lin J; Chen R; Huang Y; Liu Y; Bai J; Ge G; Shi X; Chen Y; Shi J; Aiqing L; Yang H; Geng D; Wang Z
    Oxid Med Cell Longev; 2020; 2020():6797154. PubMed ID: 32566094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PEGDA/HA mineralized hydrogel loaded with Exendin4 promotes bone regeneration in rat models with bone defects by inducing osteogenesis.
    Liu W; Jing X; Xu Z; Teng C
    J Biomater Appl; 2021 May; 35(10):1337-1346. PubMed ID: 33467965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abaloparatide: Recombinant human PTHrP (1-34) anabolic therapy for osteoporosis.
    Chew CK; Clarke BL
    Maturitas; 2017 Mar; 97():53-60. PubMed ID: 28159062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone mineral density response rates are greater in patients treated with abaloparatide compared with those treated with placebo or teriparatide: Results from the ACTIVE phase 3 trial.
    Miller PD; Hattersley G; Lau E; Fitzpatrick LA; Harris AG; Williams GC; Hu MY; Riis BJ; Russo L; Christiansen C
    Bone; 2019 Mar; 120():137-140. PubMed ID: 30359763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Photo-cross-linkable methacrylated gelatin and hydroxyapatite hybrid hydrogel for modularly engineering biomimetic osteon.
    Zuo Y; Liu X; Wei D; Sun J; Xiao W; Zhao H; Guo L; Wei Q; Fan H; Zhang X
    ACS Appl Mater Interfaces; 2015 May; 7(19):10386-94. PubMed ID: 25928732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Injectable Multifunctional Drug Delivery System for Hard Tissue Regeneration under Inflammatory Microenvironments.
    Bordini EAF; Ferreira JA; Dubey N; Ribeiro JS; de Souza Costa CA; Soares DG; Bottino MC
    ACS Appl Bio Mater; 2021 Sep; 4(9):6993-7006. PubMed ID: 35006932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Laponite modified methacryloyl gelatin hydrogel with controlled release of vascular endothelial growth factor a for bone regeneration.
    Mi B; Zhang J; Meng H; Xu Y; Xie J; Hao D; Shan L
    Biochem Biophys Res Commun; 2024 Nov; 733():150714. PubMed ID: 39326258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.